Document Type: Original Article


1 Department of Parasitology and Mycology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

2 Department of Parasitology, Laboratory Science Research Center, Faculty of Paramedical, Golestan University of Medical Sciences, Gorgan, Iran

3 Kalaleh Health Center, Golestan University of Medical Sciences, Gorgan, Iran


Background and aims: Cutaneous leishmaniasis is a major health issue in many parts of Iran.
Diagnosis of cutaneous leishmaniasis in a non-endemic area is not as simple as that in endemic foci.
The management and treatment of this disease are global dilemmas. The purpose of this study was to
identify Leishmania species isolated from human cutaneous leishmaniasis lesions in patients referred
to health centers of Golestan province, Iran.
Methods: Cutaneous leishmaniasis patients with suspected lesions were clinically examined. History
of journey to the endemic areas of zoonotic cutaneous leishmaniasis and/or anthroponotic cutaneous
leishmaniasis and the characteristics of their lesion(s) were recorded. Diagnosis of the lesion was done
by using direct smear microscopy and conventional polymerase chain reaction.
Results: Out of 360 patients, 202 (57.4 %) were male and 158 (42.8 %) were female. A total of 360
samples were selected from different cities. The number of infected samples in the cities is as follows:
Azad Shahr [3 (1.5%)], Aq Qala [11 (5.7%)], Ali Abad [4 (2.1%)], Bandar Turkmen [3 (1.5%)], Bandar
Gaz [2 (1%)], Ramian [3 (1.5%)], Kalaleh [23 (12.1%)], Kord koy [1 (0.5%)], Galikesh [7 (3.7 %)],
Gomishan [12 (3.6 %)], Gorgan [13 (6.8 %)], Gonbad Qabus [99 (52.1 %)], Marave Tappe [7 (3.6%)]
and Minoodasht [2 (1%)]. In the molecular investigations, 186 (96.8%) samples were observed to
acquire rural cutaneous leishmaniasis, 4 (2.1%) to acquire urban cutaneous leishmaniasis and 170
(47.2%) to be uninfected.
Conclusion: Although history of visiting endemic areas is an important factor to be considered in
diagnosis, parasitological confirmation is necessary for the initiation of treatment.


Main Subjects

1. Mirzaei F, Bafghi AF, Mohaghegh MA, Jaliani HZ, Faridnia R,
Kalani H. In vitro anti-leishmanial activity of Satureja hortensis
and Artemisia dracunculus extracts on Leishmania major
promastigotes. J Parasit Dis. 2016;40(4):1571-4. doi: 10.1007/
2. Hajjaran H, Vasigheh F, Mohebali M, Rezaei S, Mamishi S,
Charedar S. Direct diagnosis of Leishmania species on serosity
materials punctured from cutaneous leishmaniasis patients
using PCR-RFLP. J Clin Lab Anal. 2011;25(1):20-4. doi:
3. Mirzaie F, Eslami G, Yosefi MH, Pestehchian N. Molecular
identification of Leishmania isolates obtained from patients
suspected as having cutaneous leishmaniasis referred to
reference laboratories from Yazd province in central Iran. Adv
Biomed Res. 2013;2:92. doi: 10.4103/2277-9175.122525.
4. Nemati S, Fazaeli A, Hajjaran H, Khamesipour A, Anbaran
MF, Bozorgomid A, et al. Genetic diversity and phylogenetic
analysis of the Iranian Leishmania parasites based on HSP70
gene PCR-RFLP and sequence analysis. Korean J Parasitol.
2017;55(4):367-74. doi: 10.3347/kjp.2017.55.4.367.
5. Edrisiyan GH. Visceral Leishmaniasis in Iran and the role
of serological tests in the diagnosis and epidemiological
studies. Journal of Kerman University of Medical Sciences.
6. Khatami A, Firooz A, Gorouhi F, Dowlati Y. Systematic
review of New World cutaneous leishmaniasis: several
points. Int J Dermatol. 2009;48(2):201; author reply -2. doi:
7. Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, et
al. Leishmaniasis worldwide and global estimates of its
incidence. PLoS One. 2012;7(5):e35671. doi: 10.1371/
8. Yaghoobi-Ershadi MR, Hanafi-Bojd AA, Javadian E, Jafari R,
Zahraei-Ramazani AR, Mohebali M. A new focus of cutaneous
leishmaniasis caused by Leishmania tropica. Saudi Med J.
9. Tashakori M, Kuhls K, Al-Jawabreh A, Mauricio IL, Schonian
G, Farajnia S, et al. Leishmania major: genetic heterogeneity of
Iranian isolates by single-strand conformation polymorphism
and sequence analysis of ribosomal DNA internal transcribed
spacer. Acta Trop. 2006;98(1):52-8. doi: 10.1016/j.
10. Tesh RB, Modi GB. A simple method for experimental infection
of phlebotomine sand flies with Leishmania. Am J Trop Med
Hyg. 1984;33(1):41-6.
11. Lachaud L, Marchergui-Hammami S, Chabbert E, Dereure J,
Dedet JP, Bastien P. Comparison of six PCR methods using
peripheral blood for detection of canine visceral leishmaniasis.
J Clin Microbiol. 2002;40(1):210-5.
12. Spotin A, Rouhani S, Ghaemmaghami P, Haghighi A,
Zolfaghari MR, Amirkhani A, et al. Different morphologies of
Leishmania major amastigotes with no molecular diversity in a
neglected endemic area of zoonotic cutaneous leishmaniasis
in Iran. Iran Biomed J. 2015;19(3):149-59.
13. Monroy-Ostria A, Nasereddin A, Monteon VM, Guzman-
Bracho C, Jaffe CL. ITS1 PCR-RFLP diagnosis and
characterization of Leishmania in clinical samples and strains
from cases of human cutaneous leishmaniasis in states
of the Mexican Southeast. Interdiscip Perspect Infect Dis.
2014;2014:607287. doi: 10.1155/2014/607287.
14. Rotureau B. Ecology of the leishmania species in the Guianan
ecoregion complex. Am J Trop Med Hyg. 2006;74(1):81-96.
15. Schonian G, Nasereddin A, Dinse N, Schweynoch C, Schallig
HD, Presber W, et al. PCR diagnosis and characterization of
Leishmania in local and imported clinical samples. Diagn
Microbiol Infect Dis. 2003;47(1):349-58.
16. Yehia L, Adib-Houreih M, Raslan WF, Kibbi AG, Loya A, Firooz
A, et al. Molecular diagnosis of cutaneous leishmaniasis and
species identification: analysis of 122 biopsies with varied
parasite index. J Cutan Pathol. 2012;39(3):347-55. doi:
17. Ghasemloo H, Rasti S, Delavari M, Doroodgar A. Molecular
Diagnosis of Clinical Isolates of Cutaneous Leishmaniasis 

Using ITS1 and KDNA Genes and Genetic Polymorphism of
Leishmania in Kashan, Iran. Pak J Biol Sci. 2016;19(3):136-42.
doi: 10.3923/pjbs.2016.136.142.
18. Karamian M, Kuhls K, Hemmati M, Ghatee MA. Phylogenetic
structure of Leishmania tropica in the new endemic focus
Birjand in East Iran in comparison to other Iranian endemic
regions. Acta Trop. 2016;158:68-76. doi: 10.1016/j.
19. Roelfsema JH, Nozari N, Herremans T, Kortbeek LM, Pinelli E.
Evaluation and improvement of two PCR targets in molecular
typing of clinical samples of Leishmania patients. Exp Parasitol.
2011;127(1):36-41. doi: 10.1016/j.exppara.2010.06.024.
20. Gasser RB, Stevenson LA, Chilton NB, Nansen P, Bucknell
DG, Beveridge I. Species markers for equine strongyles
detected in intergenic rDNA by PCR-RFLP. Mol Cell Probes.
1996;10(5):371-8. doi: 10.1006/mcpr.1996.0050.
21. Chargui N, Bastien P, Kallel K, Haouas N, Akrout FM,
Masmoudi A, et al. Usefulness of PCR in the diagnosis of
cutaneous leishmaniasis in Tunisia. Trans R Soc Trop Med Hyg.
2005;99(10):762-8. doi: 10.1016/j.trstmh.2005.06.002.
22. Jirku M, Zemanova E, Al-Jawabreh A, Schonian G, Lukes
J. Development of a direct species-specific PCR assay
for differential diagnosis of Leishmania tropica. Diagn
Microbiol Infect Dis. 2006;55(1):75-9. doi: 10.1016/j.
23. Behravan MR, Moin-Vaziri V, Haghighi A, Rahbarian N,
Taghipour N, Abadi A, et al. Molecular identification of
Leishmania species in a re-emerged focus of cutaneous
leishmaniasis in Varamin district, Iran. J Arthropod Borne Dis.
24. Eslami G, Anvarii H, Ebadi M, Nabipour Y, Mirzaei F,
Gholamrezaei M, et al. The changing profile of cutaneous
leishmaniasis agent in a central province of Iran. Tanzan J
Health Res. 2013;15(1):33-9.
25. El-Beshbishy HA, Al-Ali KH, El-Badry AA. Molecular
characterization of cutaneous leishmaniasis in Al-Madinah Al-
Munawarah province, western Saudi Arabia. Int J Infect Dis.
2013;17(5):e334-8. doi: 10.1016/j.ijid.2012.11.015.
26. Al-Nahhas SA, Kaldas RM. Characterization of Leishmania
species isolated from cutaneous human samples from
central region of Syria by RFLP analysis. ISRN Parasitol.
2013;2013:308726. doi: 10.5402/2013/308726.
27. Marfurt J, Nasereddin A, Niederwieser I, Jaffe CL, Beck HP,
Felger I. Identification and differentiation of Leishmania
species in clinical samples by PCR amplification of the
miniexon sequence and subsequent restriction fragment length
polymorphism analysis. J Clin Microbiol. 2003;41(7):3147-53.